Show simple item record

Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia

dc.contributor.authorTiger, Mikael
dc.contributor.authorWesselhoeft, Rikke
dc.contributor.authorKarlsson, Pär
dc.contributor.authorHandal, Marte
dc.contributor.authorBliddal, Mette
dc.contributor.authorCesta, Carolyn E.
dc.contributor.authorSkurtveit, Svetlana Ondrasova
dc.contributor.authorReutfors, Johan
dc.date.accessioned2023-01-06T11:28:20Z
dc.date.available2023-01-06T11:28:20Z
dc.date.created2023-01-04T16:00:21Z
dc.date.issued2022
dc.identifier.citationJournal of Affective Disorders. 2022, 323 292-298.
dc.identifier.issn0165-0327
dc.identifier.urihttps://hdl.handle.net/11250/3041536
dc.language.isoeng
dc.titleUtilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia
dc.title.alternativeUtilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber292-298
dc.source.volume323
dc.source.journalJournal of Affective Disorders
dc.identifier.doi10.1016/j.jad.2022.11.068
dc.identifier.cristin2100782
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail
Name:
Tiger_2022_Uti.pdf
Size:
4.169Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record